Microglial Activatory (immunoreceptor Tyrosine-based Activation Motif)- and Inhibitory (immunoreceptor Tyrosine-based Inhibition Motif)-signaling Receptors for Recognition of the Neuronal Glycocalyx
Authors
Affiliations
Microglia sense intact or lesioned cells of the central nervous system (CNS) and respond accordingly. To fulfill this task, microglia express a whole set of recognition receptors. Fc receptors and DAP12 (TYROBP)-associated receptors such as microglial triggering receptor expressed on myeloid cells-2 (TREM2) and the complement receptor-3 (CR3, CD11b/CD18) trigger the immunoreceptor tyrosine-based activation motif (ITAM)-signaling cascade, resulting in microglial activation, migration, and phagocytosis. Those receptors are counter-regulated by immunoreceptor tyrosine-based inhibition motif (ITIM)-signaling receptors, such as sialic acid-binding immunoglobulin superfamily lectins (Siglecs). Siglecs recognize the sialic acid cap of healthy neurons thus leading to an ITIM signaling that turns down microglial immune responses and phagocytosis. In contrast, desialylated neuronal processes are phagocytosed by microglial CR3 signaling via an adaptor protein containing an ITAM. Thus, the aberrant terminal glycosylation of neuronal surface glycoproteins and glycolipids could serve as a flag for microglia, which display a multitude of diverse carbohydrate-binding receptors that monitor the neuronal physical condition and respond via their ITIM- or ITAM-signaling cascade accordingly.
The pivotal role of microglia in injury and the prognosis of subarachnoid hemorrhage.
Ning W, Lv S, Wang Q, Xu Y Neural Regen Res. 2024; 20(7):1829-1848.
PMID: 38993136 PMC: 11691474. DOI: 10.4103/NRR.NRR-D-24-00241.
Microglia in Alzheimer's disease: pathogenesis, mechanisms, and therapeutic potentials.
Miao J, Ma H, Yang Y, Liao Y, Lin C, Zheng J Front Aging Neurosci. 2023; 15:1201982.
PMID: 37396657 PMC: 10309009. DOI: 10.3389/fnagi.2023.1201982.
Muscat S, Butler M, Mackey-Alfonso S, Barrientos R Brain Res Bull. 2023; 195:145-156.
PMID: 36870621 PMC: 10257807. DOI: 10.1016/j.brainresbull.2023.03.001.
Modulation of C5a-C5aR1 signaling alters the dynamics of AD progression.
Carvalho K, Schartz N, Balderrama-Gutierrez G, Liang H, Chu S, Selvan P J Neuroinflammation. 2022; 19(1):178.
PMID: 35820938 PMC: 9277945. DOI: 10.1186/s12974-022-02539-2.
Han X, Han J, Wang N, Ji G, Guo R, Li J Front Neurosci. 2022; 16:891670.
PMID: 35720684 PMC: 9204148. DOI: 10.3389/fnins.2022.891670.